Valuation : Abera Bioscience AB

Market Cap 162M 16.84M 14.53M 13.67M 12.46M 23.41M 1.6B 23.57M 62.9M 813M 63.22M 61.84M 2.72B P/E 2024
-64.4x
P/E 2025 -10.8x
Enterprise Value 138M 14.4M 12.42M 11.69M 10.66M 20.02M 1.37B 20.15M 53.77M 695M 54.05M 52.87M 2.33B EV / Sales 2024
4.32x
EV / Sales 2025 8.6x
Free-Float
40.83%
Yield 2024 *
-
Yield 2025 -
1 day-0.75%
1 week-2.95%
Current month-0.75%
1 month-5.95%
3 months+11.27%
6 months+36.21%
Current year+16.18%
1 week 7.52
Extreme 7.52
8.22
1 month 7.52
Extreme 7.52
8.94
Current year 5.15
Extreme 5.15
10.05
1 year 5.15
Extreme 5.15
10.05
3 years 3.24
Extreme 3.24
10.05
5 years 3.05
Extreme 3.05
30.8
10 years 3.05
Extreme 3.05
30.8
Manager TitleAgeSince
Chief Executive Officer 43 01/10/2020
Chief Tech/Sci/R&D Officer 66 03/11/2012
Chief Tech/Sci/R&D Officer 61 01/05/2022
Director TitleAgeSince
Chairman 56 01/01/2015
Director/Board Member 59 01/01/2020
Director/Board Member 74 01/01/2020
Date Insider Type Main position Quantity % Market Cap. Importance
21/01/22 Buy

Chairman

12,000 0.1147%
Change 5-day change 1-year change 3-year change Capi.($)
-0.75%-2.95%-0.63%+96.03% 17.03M
+0.21%-1.70%+1.90%+18.18% 49.81B
+2.09%-0.81%+452.73%+517.81% 44.06B
-1.09%-0.73%+35.40%+16.04% 42.99B
-0.26%-3.58%+17.19%+72.80% 40.88B
-0.48%-3.09%+17.78%+49.80% 33.11B
-1.81%-5.94%+22.65%+115.79% 16.58B
-1.06%+3.29% - - 17.27B
-1.35%-2.32%+10.40%+25.90% 14.63B
-2.05%-5.44%+72.89%+36.51% 13.76B
Average -0.80%-1.86%+70.03%+105.43% 27.31B
Weighted average by Cap. -0.48%-1.79%+95.32%+124.45%

Financials

2024 2025
Net sales 14.63M 1.52M 1.31M 1.23M 1.13M 2.11M 144M 2.13M 5.68M 73.45M 5.71M 5.59M 246M 11.85M 1.23M 1.06M 1M 912K 1.71M 117M 1.73M 4.6M 59.5M 4.63M 4.53M 199M
Net income -1.1M -114K -98.67K -92.84K -84.66K -159K -10.86M -160K -427K -5.52M -429K -420K -18.47M -10.45M -1.09M -938K -882K -804K -1.51M -103M -1.52M -4.06M -52.48M -4.08M -3.99M -176M
Net Debt -6.09M -633K -546K -514K -469K -880K -60.12M -886K -2.37M -30.58M -2.38M -2.33M -102M -23.49M -2.44M -2.11M -1.98M -1.81M -3.4M -232M -3.42M -9.12M -118M -9.17M -8.97M -395M
Logo Abera Bioscience AB
Abera Bioscience AB is a Sweden-based company, which is active in biotechnology. Abera Bioscience is platform and vaccine development company active in the medical, molecular and microbiological field. The Company’s purpose is to develop vaccine candidates based on its vaccine delivery platform to late pre-clinical or early clinical phase and to find licensing partners for further development of the vaccines. The technology is mainly used in the development of new vaccines where the focus is on the main areas of pneumococci and immunooncology. The business is located around the Nordic market.
Employees
6
Date Price Change Volume
01/09/26 SEK 7.900 -0.75% 4,678
31/08/26 SEK 7.960 -2.21% 338
28/08/26 SEK 8.140 -0.25% 2,867
27/08/26 SEK 8.160 -0.73% 1,235
26/08/26 SEK 8.220 +0.49% 411

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABERA Stock